СLINICAL AND IMMUNOLOGICAL EFFICIENCY OF IMUNOFAN AND POLYOXIDONIUM IN COMBINED THERAPY OF COMMUNITY-ACQUIRED PNEUMONIA
Abstract. A study was carried out in hundred-five patients with severe or mid-severe clinical course
of community-acquired pneumonia. Clinical observations showed that introduction of Imunofan and
Polyoxidonium within combined therapeutic regimen administered to the patients, exerts a pronounced positive effect upon clinical course of disease and normalization of immune characteristics. Due to immunocorrective treatment with Imunofan and Polyoxidonium, the patients with community-acquired pneumonia, exhibited a distinct trend to earlier normalization of both cellular and humoral immunity indexes. This result provides further proofs for efficient treatment with immunomodulatory drugs, e.c., by means of Imunofan and Polyoxidonium.
Document Type: Research Article
Affiliations: Башкирский государственный медицинский университет, г. Уфа
Publication date: 01 January 2009
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content